Armistice Capital, LLC Prothena Corp Public LTD CO Transaction History
Armistice Capital, LLC
- $5.71 Billion
- Q2 2025
A detailed history of Armistice Capital, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Armistice Capital, LLC holds 2,236,000 shares of PRTA stock, worth $16.9 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
2,236,000
Previous 2,196,000
1.82%
Holding current value
$16.9 Million
Previous $27.2 Million
50.08%
% of portfolio
0.24%
Previous 0.41%
Shares
7 transactions
Others Institutions Holding PRTA
# of Institutions
218Shares Held
34.1MCall Options Held
879KPut Options Held
791K-
Black Rock Inc. New York, NY3.86MShares$29.1 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$25.4 Million3.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$16.4 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$9.61 Million1.75% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.18MShares$8.91 Million0.01% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $354M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...